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Background: Polyketides are one of the most important classes of secondary metabolites and usually make good
drugs. Currently, heterologous production of fungal polyketides for developing a high potential industrial
application system with high production capacity and pharmacutical feasibility was still at its infancy. Pichia pastoris
is a highly successful system for the high production of a variety of heterologous proteins. In this work, we aim to
develop a P. pastoris based in vivo fungal polyketide production system for first time and evaluate its feasibility for
future industrial application.
Results: A recombinant P. pastoris GS115-NpgA-ATX with Aspergillus nidulans phosphopantetheinyl transferase
(PPtase) gene npgA and Aspergillus terrus 6-methylsalicylic acid (6-MSA) synthase (6-MSAS) gene atX was
constructed. A specific compound was isolated and idenified as 6-MSA by HPLC, LC-MS and NMR. Transcription of
both genes were detected. In 5-L bioreactor, the GS115-NpgA-ATX grew well and produced 6-MSA quickly until
reached a high value of 2.2 g/L by methanol induction for 20 hours. Thereafter, the cells turned to death ascribing
to high concentration of antimicrobial 6-MSA. The distribution of 6-MSA changed that during early and late
induction phase it existed more in supernatant while during intermediate stage it mainly located intracellular.
Different from 6-MSA production strain, recombinant M. purpureus pksCT expression strains for citrinin intermediate
production, no matter PksCT located in cytoplasm or in peroxisomes, did not produce any specfic compound.
However, both npgA and pksCT transcripted effectively in cells and western blot analysis proved the expression of
PPtase. Then the PPTase was expressed and purified, marked by fluorescent probes, and reacted with purified ACP
domain and its mutant ACPm of PksCT. Fluoresence was only observed in ACP but not ACPm, indicating that the
PPTase worked well with ACP to make it bioactive holo-ACP. Thus, some other factors may affect polyketide
synthesis that include activities of the individual catalytic domains and release of the product from the synthase of
PksCT.
Conclusions: An efficient P. pastoris expression system of fungal polyketides was successfully constructed. It
produced a high production of 6-MSA and holds potential for future industrial application of 6-MSA and other
fungal polyketides.
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Polyketides are one of the most important classes of sec-
ondary metabolites. They occur in bacteria, fungi, plants,
marine organisms, etc., showing flexible structural diver-
sity and a variety of bioactivities [1]. Polyketides and their
derivatives make good drugs. As reported by Weissman
and Leadlay in 2005, polyketide-derived pharmaceuticals
comprise 20% of the top-selling drugs, with combined
worldwide revenues of over UK £10 billion per year [2].
Many important drugs have suffered or will face expi-
ration of the key patents, which is likely to lead to explo-
sive production growth of these compounds [3].
During the last two decades, the biosynthetic mechanism
of polyketides catalyzed by polyketide synthase (PKS) have
been well interpreted despite that some highly controlled
synthetic processes still remained unknown. As is known,
fungal PKSs belong to iterative type I PKS that contains an
obligatory set of ketosynthase (KS), acyltransferase (AT)
and acyl carrier protein (ACP) domains, which is closely
related to fatty acid biosynthesis [1].The ACP domains
carry the malonyl extender units and transiently link the
growing acyl chain. Before functioning, the apo-ACP re-
quires post-translational modification to be holo-ACP
through the addition of phosphopantetheine (PP) derived
from coenzyme A (CoA) to a conserved serine residue cat-
alyzed by phosphopantetheinyl transferase (PPtase). The
Claisen condensation is catalyzed by the KS while the AT
transfers acyl groups from CoA onto the KS and ACP
domains. The resulted β-ketothioester could be further
processed by β-ketoacyl reductase (KR), dehydratase (DH)
and/or enoyl reductase (ER) to form an ester with different
degree of saturation. Fungal PKS can own another
intrinsic domain C-methyl transferase (CMeT) that ad-
ditionally methylated the chain using a methyl group
from S-adenosylmethionine (SAM). Once the polyketide
chain has finished, a thioesterase (TE) hydrolyses the
thioester and releases the carbon chain from the enzyme,
although it is not found in every PKS. The recycling
mechanism of fungal type I PKS makes the biosynthesis
process efficiently with relatively small genes.
Due to the broad bioactivity and well known synthesis
mechanism of polyketides their production have attracted
much interest in the field of metabolic engineering. To
present, several hosts, i.e., E.coli, Saccharomyces cerevisiae,
Streptomyces coelicolor, Aspergillus nidulans, Aspergillus
oryzae, etc., have already been accomplished for polyketides
biosynthesis [4]. An reconstruction of a complete func-
tional fungal biosynthetic multigene cluster even succeeded
in A. oryzae [5]. However, these studies mainly focused on
identifying the functions of PKSs, performing combina-
tional biochemistry for new compound biosynthesis, or
testing the feasibility of the expression system, while the
work for developing a high potential industrial application
system with high production capacity of pharmaceuticalcompound was still at its infancy. It is believed that, com-
binational biochemistry would play an important role in fu-
ture drug development and explore a highly efficient
heterologous production system turns to be critical.
As is known, Pichia pastoris is well used as a highly
successful system for the production of a variety of
heterologous proteins in both laboratory and industry
[6,7]. For P. pastoris, the simple molecular genetic ma-
nipulation and commercially available kit made it con-
veniently for laboratory and industrial application. It can
produce foreign proteins at high levels under control of
methanol-inducible strong promoter AOX1, either intra-
cellularly or extracellularly. Moreover, it has the capabil-
ity of directing proteins into peroxisome and performing
many eukaryotic post-translational modifications, such
as glycosylation, disulfide bond formation and proteo-
lytic processing. However, till now, there is few reports
focused on polyketide synthase (PKS) expression trigger-
ing compound biosynthesis in vivo by P. pastoris.
The PKS of 6-methylsalicylic acid (6-MSA) synthase
(6-MSAS) responsible for 6-MSA biosynthesis was the
first fungal PKS gene to be cloned and is also one of the
best characterized fungal PKSs [8-10]. It has been com-
monly used as a model PKS for evaluation of heterolo-
gously expression system such as S. cerevisiae [3,11],
S. coelicolor [12], E. coli [13], tobacco [14]. Mycotoxin ci-
trinin was originally isolated from Penicillium citrinum
and now produced by a variety of other fungi [15]. It
damages human health and usually accompanies with
pigment production in Monascus spp., and gives rise to
wide attention. A gene cluster for biosynthesis of myco-
toxin citrinin have been reported, in which, a pksCT
plays an important role and probably responsible for its
intermediate biosynthesis [16,17]. For heterologous pro-
duction of polyketide in yeast, the post-translational
modification of the ACP by phosphopantetheinylation is
necessary. As previously reported, this challenge could
be solved by the PPTase encoding genes of npgA from A.
nidulans or sfp from Bacillus subtilis [3,13].
In this work, we dedicated to establish a P. pastoris based
polyketide production system. The synthetic pathway of
model fungal polyketide 6-methylsalicylic acid encoded by
atX from Aspergillus terreus [10,18] and citrinin intermedi-
ate encoded by pksCT from Monascus purpureus were
constructed to verify the feasibility of heterologous produc-
tion of fungal polyketide in P. pastoris. Besides, bioreactor
fermentation was also performed to evaluate the polyketide
productivity of the recombinant strain.
Results and discussion
Construction of strain GS115-NpgA, GS115-ATX and
GS115-NpgA-ATX
For polyketide biosynthesis, the ACP functions after
post-translational modification by phosphopantetheine
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phosphopantetheine from coenzyme A (CoA) to a con-
served serine residue of ACP [1]. In this study, A.
nidulans npgA (GenBank: AAF12814) encoding the
PPTase consisted of 344 amino acids was selected.
Strains were constructed following Section Plasmids and
strains. Commercial vector pPIC3.5 K (Invitrogen) with
AOX1 promoter and selective marker HIS4 was used for
plasmid pPIC3.5 K-NpgA construction and then trans-
formed auxotrophic his4 wild type P. pastoris GS115 by
a single homologous recombination event to integrate at
HIS4 locus. A positive transformant P. pastoris GS115-
NpgA was screened and fully identified by PCR. The
6-MSAS containing 1803 amino acids encoded by atX
(GenBank: D85860) from A. terrus was expressed by
P. pastoris and purified with Nickel-affinity chromato-
graphy. The intron removed atX was cloned from a gift
plasmid pESC-ATX. The vector pPICZ B (Invitrogen)
with AOX1 promoter and selective marker of zeocin
resistance gene Sh ble was used for plasmid pPICZ
B-ATX construction and then transformed P. pastoris
GS115 and recombinant P. pastoris GS115-NpgA by
single homologous recombination events to integrate at
5′AOX1 region. The positive methanol utilization
plus (Mut+) transformants GS115-ATX and GS115-
NpgA-ATX were screened and fully identified by PCR
analysis.
Product identification of GS115-NpgA-ATX
Three strains, GS115, GS115-ATX and GS115-NpgA-ATX,
were cultivated under same conditions. After methanol
induced expression for 36 h, the products were ex-
tracted and analyzed by HPLC analysis. As shown in
Figure 1, GS115-NpgA-ATX produced a specfic com-
pound emerged as a sharp peak in HPLC chromatogram
at 16.7 min compared with GS115 and GS115-ATX,
which had the same retention time as an authentic
sample of 6-MSA under this elution condition. To
further confirm the structure of the compound, the
extracts were purified by TLC (petroleum ether:ethyl
acetate = 3:1 (v/v), 1% acetic acid) and extracted and
freeze-dried for further EI-MS and NMR analysis. The
EI-MS analysis was performed on an Agilent G2577A
mass spectrometer, establishing the molecular formulae
as C8H8O3 for 6-MSA (with the M
+ ion at m/z =
152.0474, 152.0473 calculated) absolutely accorded with
the standard 6-MSA (Figure 2A). The freeze-dried sam-
ple dissolved in deuterated DMSO for 1HNMR analysis.
The results that 1HNMR (400 MHz, DMSO-d6),
δH = 6.37 (1H, m, H-3), 6.94 (1H, m, H-4), 6.46 (1H,
m, H-5), 2.52 (3H, s, CH3-6) conformed with
1HNMR
spectrum of standard 6-MSA and further confirmed the
compound (Figure 2B). For all three tested strains, only
GS115-NpgA-ATX produced 6-MSA but not GS115-ATX and wild type GS115, proving that 6-MSAS could
be well modified by PPtase and it only works for 6-MSA
biosynthesis after PPtase modification. Furthermore,
transcription analysis of GS115 and GS115-NpgA-ATX
were carried out after 24 hours induction. Three pairs
of primers, 5AOX1/3AOX1, NpgAF/NpgAR1, BstpF/
AtxR, were used to test gene transcriptions of AOX1,
npgA and atX. The wild type GS115 only generated the
correct nucleic acid size of 2.2 kb for the AOX1, while
GS115-NpgA-ATX formed other two desired PCR
products (1.3 kb for npgA and 1.9 kb for atX) besides
the AOX1 (Figure 2C), indicating that both npgA and
atX transcripted effectively in the recombinant strain
GS115-NpgA-ATX.
Fermentation of GS115-NpgA-ATX in 5-L bioreactor
A 5-L bioreactor fermentation was subsequently conducted
to evaluate the productivity of 6-MSA by the recombinant
GS115-NpgA-ATX. As shown in Figure 3, a batch phase in
BSM medium proceeded until 32 h when glycerol used up
accompanied with dissolved oxygen sharply increase, and
reached a wet cell weight (WCW) of 112 g/L. A fed-batch
phase continued with limited feedings of glycerol feeding
medium to improve cell growth until 46 h when a high cell
density of 252 g/L (WCW) was achieved. Then, methanol
induction phase started at 47 h after glycerol exhaused with
derepression of AOX1 promoter. The 6-MSA rapidly
synthesized and accumulated. After induction for 20 hours,
6-MSA production reached up to the highest 2.2 g/L. How-
ever, the culture broth turned extremely abnormal and cells
turned to death by methylene blue staining analysis. During
methanol induction phase, cell growth was highly re-
pressed, which should be ascribed to the antimicrobial
activity of 6-MSA [19]. The repression effect of 6-MSA on
P. pastoris growth was subsequently verified in 5-L biore-
actor fermentation with commerially purchased 6-MSA
addition with final concentration of 2.05 g/L immediately
after WCW reached 235 g/L (Additional file 1: Figure S1).
For GS115-NpgA-ATX, the distribution of 6-MSA changed
that during early induction phase and late phase it existed
more in supernatant while during intermediate stage it
mainly located intracellular. It might attribute to that the
increased methanol feeding rate up-regulated the expres-
sion rate of 6-MSAS so that enhanced 6-MSA synthesis.
The rapidly accumulated 6-MSA could not be efficiently
transferred extracellular. However, during the late induction
phase, the death of cells may accelarated 6-MSA release to
fermentation broth.
Kealey et al. reported a heterogous expression of
6-MSA with a low production of 75 mg/L in E. coli
and a high production of 1.7 g/L in S. cerevisiae with
coexpression of Penicillium patulum MSAS and B.
subtilis SFP [13]. Wattanachaisaereekul et al. obtained a
6-MSA production of 0.2 g/L by heterologous expression
Figure 1 The HPLC chromatogram of organic extracts from fermentation broth of strain GS115, GS115-ATX and GS115-NpgA-ATX.
Samples preparation were described in the Section 6-MSA extraction and identification in Methods.
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timized the expression by swapping promoter PACC1 to a
strong, constitutive promoter PTEP1 to increase malonyl-
CoA supply and resulted in an increased 6-MSA produc-
tion of 0.5 g/L [20]. The 6-MSA of 2.2 g/L in this case is
higher than these published data. It could be further to go
by promoting cell density before methanol inducation or
developing a fermentation and bioseparation coupling
process that releasing 6-MSA from broth to keep cell alive.
Product, transcription and western blot analysis of PksCT
expression strains
The previous study showed that a 56 bp intron
presented at 640 to 695 bp, flanked by a typical splice
site (5′-GT-AG-3′) in pksCT, a gene critical for citrinin
biosynthesis in M. purpureus [21]. The PksCT possessed
KS-AT-ACP-MT domains but no TE domain [21]. How-
ever, in this study, we found another intron located at6547 to 6608 bp beside the reported one by RT-PCR.
The cDNA of pksCT by removing two introns were
6507 bp, coded for 2169 amino acids, which also
contained the intact KS-AT-ACP-MT domains. The ex-
pression strains, i.e., GS115-3.5 K, GS115-3.5 K-CT-SKL,
GS115-NpgA-CT-SKL, GS115-NpgA-SKL-CT-SKL and
GS115-NpgA-CT, were then constructed as that des-
cribed in Methods and the integration mechanism were
the same to construction of atX recombinant strains.
However, different from 6-MSAS expression strains,
none of them produced specific compound comparing
with the control GS115 by HPLC-MS. The strains ex-
pressing pksCT that only removed the front 56 bp intron
were also constructed but were still nothing different
(data not shown).
Transcription of GS115-3.5 K-CT-SKL, GS115-NpgA-CT
and GS115-NpgA-SKL-CT-SKL were then analyzed after
24 hours induction. Two pairs of primers, NpgA-HIS6-F/
Figure 2 The EI-MS identification of product 6-MSA by GS115-NpgA-ATX and transcription analysis of npgA and atX. (A) EI-MS analysis
of extract from GS115-NpgA-ATX. m/z, mass-to-charge ratio; (B) The 1HNMR analysis of extract from GS115-NpgA-ATX. Samples preparation were
in the Section 6-MSA extraction and identification in Methods; (C) Lane 1–3: PCR using cDNA of wild type GS115 and primers 5AOX1/3AOX1,
NpgA-F/R1 and BstpF/AtxR, respectively; Lane 4–6: PCR using GS115-NpgA-ATX cDNA and primers 5AOX1/3AOX1, NpgAF/ NpgAR1 and
BstpF/AtxR, respectively; M: DNA marker Hind III. Gene transcription induced by 0.5% methanol for 24 h.
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transcriptions of npgA and pksCT. GS115-3.5 K-CT-SKL
acted no npgA transcription but GS115-NpgA-CT and
GS115-NpgA-SKL-CT-SKL did (1.1 kb) (Figure 4A). As
for pksCT, all three strains transcripted normally (2.1 kb)
(Figure 4B). A western blot analysis detecting PPtase
expression was further applied (Figure 4C). The GS115-
NpgA-CT and GS115-NpgA-SKL-CT-SKL clearly pre-
sented the PPtase band of about 40 KDa while neitherdid GS115 nor GS115-3.5 K-CT-SKL. These results sug-
gested that genes transcription and PPtase expression
functioned well.
Phosphopantetheinylation activity analysis of PPTase on
ACP domain of PksCT
To determine whether or not A. nidulans PPtase could
react with ACP domain of M. purpureus PksCT, an in vitro
experiment was then studied. The PPTase containing
Figure 3 Time profiles of GS115-NpgA-ATX in 5-L stirred-tank bioreactor fermentation. The first arrow (32 h) indicated the starting point of
glycerol feeding; The second arrow (47 h) indicated the starting point of methanol induction. Culture conditions were shown in Methods.
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AAF12814) was expressed by P. pastoris and purified with
Nickel-affinity chromatography. The molecular weight
(Mw) of PPtase with His taq was calculated as 40 KDa by
the software Scansite pI/Mw. As shown in Figure 5B,Figure 4 Transcription of npgA and pksCT and western blot
assay of PPtase induced by 0.5% methanol. (A) PCR with primers
NpgA-HIS6-F/ NpgA-HIS6-R; (B) PCR with primers 1977 F/4088R.
Lane 1: GS115-3.5 K-CT-SKL; Lane 2: GS115-NpgA-CT; Lane 3: GS115-
NpgA-SKL-CT-SKL. (C) Western blot of PPtase. Lane1: GS115; Lane2:
GS115-3.5 K-CT-SKL; Lane 3: GS115-NpgA-CT; Lane 4: GS115-
NpgA-SKL-CT-SKL. The arrows indicates the positive bands of
nucleic acids and proteins. Samples preparation and experimenal
procedure were shown in the Section Transcription and western
blot analysis in Methods.PPTase clearly exhibited in SDS-PAGE with a Mw about
40 Kda.
The ACP domain of fugnal PKS citrinin synthase
(PksCT) from M. purpureus was employed to test the
activity of PPtase. The ACP domain was analyzed and
determined by Udwary–Merski algorithm (UMA) pro-
cedure (Figure 5A) [22,23] relying on the assumptions
that amino acids in domain regions are relatively more
conserved while linker regions carry more mutations
and higher hydrophilicity [24]. E. coli BL21 was used for
expression of ACP and its mutant ACPm (conserved
serine at site 56 to alanine) (Figure 5A), and the proteins
clearly appeared in the SDS-PAGE with similar Mw of
about 20 Kda (Figure 5C).
The bioactivity of PPtase was evaluated based on fluo-
rescence labelled strategy. As we know, for function
of PKS, the apo-ACP requires post-translational modi-
fication to form holo-ACP through the addition of
phosphopantetheine derived from coenzyme A (CoA) to
a conserved serine residue catalyzed by PPtase. If the
conserved serine is mutated, the phosphopantetheinylation
will then fail. Fluorescent probes Alexa Fluor 647-
C2maleimide and Bodipy FL N-(2-aminoethyl)maleimide
can label phosphopantetheine by reacting with its hydro-
sulphonyl group. When fluorescently labelled 4′-phospho-
pantetheine linked with apo-ACP, the resulted holo-ACP
would show fluorescence and stabilize in the SDS-PAGE
[25]. However, once the conserved serine of ACP was mu-
tated, it could not be labelled and emit fluorescence. In
point of this study, once the PPtase encoded by A.
nidulans npgA works, Alexa Fluor-647-phosphopan-
tetheine labelled ACP would emit red fluorescence
Figure 5 Nucleotide and amino acid sequences of ACP amd SDS-PAGE of PPTase and ACP and ACPm. (A) nucleotide and amino acid
sequences ACP domain of citrinin polyketide synthase. The conserved serine at site 56 which marked by square frame was mutated by overlap
PCR using primers mutant5/mutant3 to generate ACPm. (B) SDS-PAGE of PPTase expressed by GS115-NpgA-HIS6; (C) SDS-PAGE of ACP and
ACPm expressed by E. coli BL21. Lane 1: Lysate supernatant of GS115-NpgA-HIS6; Lane 2: Flow-through fraction of GS115-NpgA-HIS6; Lane 3:
Eluted protein of GS115-NpgA-HIS6; Lane 4: Lysate supernatant of wild type E. coli BL21 strain as negative control; Lane 5: Lysate supernatant of
BL21-ACP; Lane 6: Lysate supernatant of BL21-ACPm. M: Protein marker. Protein purification were described in the Section Protein expression and
purification in Methods. The arrows indicates the objective proteins.
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Bodipy FL-phosphopantetheine labelled ACP would
emit green fluorescence with 580 nm exciting light and
670 nm filter.
As shown in Figure 6, Lane 1 and 3 were loaded with
ACPm (conserved serine at site 56 to alanine) of PksCT
that deactivating transthioesterification while Lane 2 and
4 contained the correct ACP of PksCT without muta-
tion. Bodipy FL- phosphopantetheine labelled ACP in
Lane 2 emitted green fluorescence when excited with
wavelength of 480 nm (Figure 6A), while Alexa Fluor-647- phosphopantetheine labelled ACP in Lane 4 pro-
duced red fluorescence when excited with wavelength of
580 nm (Figure 6B). However, Lane 1 and 3 emitted no
fluorescence under different wavelengths of exciting lights
and filters (Figure 6A&B). The gel was then stained by
Coomassie brilliant blue R250 solution and both ACP and
ACPm presented correct Mw (Figure 6C). The results
proved that A. nidulans PPtase possessed good bioactivity
for catalyzing modification of M. purpureus ACP. How-
ever, if the modification sites were mutated, i.e., ACPm, it
lost ability of phosphopantetheinylation so that deprived
Figure 6 Fluorescent assay of ACP and ACPm that were fluorescently labelled. The KODAK In-vivo multispectral imaging systerm F was
used for scanning. (A) Image parameter of 480 nm laser and 535 nm emission filter; (B) Image parameter of 580 nm laser and 670 nm emission
filter; (C) Image of the same SDS-PAGE gel stained with Coomassie brilliant blue R-250. Lane 1: In vitro reaction containing Bodipy FL-CoA, PPtase
and ACPm; Lane 2: In vitro reaction containing Bodipy-CoA, PPtase and ACP; Lane 3: In vitro reaction containing Alexa Fluor 647-CoA, PPtase and
ACPm; Lane 4: In vitro reaction containing Alexa Fluor 647-CoA, PPtase and ACP. Protein preparation were described in Methods.
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This indicated that inefficient phosphopantetheinylation
should not be the reason why citrinin intermediate was
not observed. Other factors may affect polyketide syn-
thesis that include activities of the individual catalytic do-
mains and release of the product from the synthase [25].
The pksCT may also be poorly active without other pro-
teins. Cox and coworkers reported that coexpression of
different genes from fungal PKS clusters could lead to in-
creased titres of objective compounds [5,26]. Coexpression
of tenB with tenA, tenC and tenS with individual pro-
moters and terminators increased Pretenellin-B by 149.2%
in heterogolous expression in A. oryzae as compared to
that without tenB [5]. Also, a hybrid fungal PKS-NRPS
system TENS-PKS:DMBS-NRPS appeared to be more ac-
tive than either of its progenitors and produced much
higher purified yields of prototenellin C [26]. Additionally,
some correct fungal polyketides may only be obtained
by coexpression of their encoded PKS genes and other re-
lated genes. For instance, expression of tenS in the absence
of a trans-acting ER component encoded by orf3 led to er-
rors in assembly of the polyketide component, while
coexpression of both genes worked correctly [27]. The
lovF encoding lovastatin nonaketide synthase only func-
tioned accurately with coexpression with lovC encoding
a trans-acting enoyl reductase in the heterologous pro-
duction of monacolin-J [28]. Sakai et al. have recently
reported a successful case of heterologous production of
citrinin in A. oryzae by involving a small citrinin gene
cluster (less than 20 kb) containing pksCT, activator gene
ctnA and other 4 ORFs [16]. It is necessary for us to ex-
press this gene cluster or coexpression pksCT with related
genes to further evaluate the P. pastoris system and probe
into the source for this unsuccessful expression of pksCT
gene.
Previous study have succeeded in heterologous pro-
duction of fungal polyketides by involving A. nidulans
PPtase, revealing that PPtase worked well on ACP of6-MSAS and LNKS origining from P. patulum and
A. terrus, respectively [13,25]. In this study, A. nidulans
PPtase reacting with ACP of M. purpureus was also
proven. These results indicated that A. nidulans PPtase
probably work on ACPs from a wide range of filament-
ous fungi.
This work revealed that P. pastoris could be a good
host that serve for heterogous expression of native poly-
ketide or engineering recombinant polyketide biosyn-
thesis in lab study. It also held great potential for
heterologous production of polyketides in industrial ap-
plication. We believed that P. pastoris could show more
strong productive ability in heterologous production of
non-lethal polyketides. Moreover, in view of the relative
ease of performing genetic engineering the metabolic
network modification may readily acheived to enhance
precursor or intermediate formation or weaken its com-
peting pathway for polyketide biosynthesis in P. pastoris.
A successful case expanding the range of starter and
extender units for polyketide biosynthesis has been illus-
trated in S. cerevisiae by introducing pathways for
methylmalonyl-CoA generation [11]. However, the P.
pastoris system may also faces the chellenges that other
hosts ever encountered. The presence of introns and
strain-specific splicing mechanisms for fungal PKS genes
may bring hardness in verification of full length cDNA
or cumbersome removal of introns [4].The huge size
of gene cluster encoding the biosynthetic pathway of
polyketides may render expression constructs instable
[4]. Also, some unknown origins caused blocks of com-
pound synthesis, such as citrinin intermediate in this
study and lovastatin precursors in S. cerevisiae [25].
Anyway, P. pastoris showed great potential to be a
good host for polyketide production, and applying P.
pastoris for a full PKS gene cluster for compound pro-
duction would deeply test out its prospect in industrial
application and becomes another research key point in
the near future.
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An efficient P. pastoris expression system of fungal
polyketides was constructed. The recombinant atX strain
successfully synthesized the objective compound 6-MSA
and produced a high concentration (2.2 g/L) of 6-MSA in
5-L bioreactor fermentation. The P. pastoris expression
system holds good potential for future industrial applica-
tion of 6-MSA and other fungal polyketides, despite that




Oligonucleotides were synthesized by Shanghai Generay
Biotech Co., Ltd., China (Table 1). For PCR experiments,
standard protocols were applied following PCR amplifi-
cation kit (TaKaRa, cat. no. R011). Fungal genomic DNA
was extracted by Plant Genomic DNA Extraction Kit
(Tiangen Biotech Co., Ltd., China). E.coli vector pET28a
was purchased from TaKaRa. P. pastoris GS115, E.coli
TOP10, E.coli BL21 and yeast vectors pPICZ B and
pPIC3.5 K were purchased from Invitrogen. A. nidulans
A1149 (TN02A3) was bought from Fungal Genetics
Stock Center, USA. Fluorescent probes Alexa Fluor 647-
C2maleimide and Bodipy FL N-(2-aminoethyl)maleimide
were purchased from Invitrogen. DNase I was bought
from Promega. Transformation of yeast cells and trans-
formants screening were carried out according to Pichia
protocols by Cregg and Russell [29]. Transformation and
other standard recombinant DNA operations used in
this study for E. coli were performed as described pre-
viously [30].
Plasmids and strains
The plasmids and strains used in this study were listed
in Table 2.
Strain GS115-NpgA , GS115-NpgA-ATX and GS115-ATX
Using primers NpgAF/NpgAR1 to amplify A. nidulans
npgA, the obtained product was diluted 10 times and
then used as DNA template to amplify npgA with C-ter-
minal c-myc-HA taq by primers NpgAF/NpgAR2. The
1116 bp product was digested with SnaBI/NotI and li-
gated into vector pPIC3.5 K opened with SnaBI/NotI to
yield the expression vector pPIC3.5 K-NpgA. After
transforming into E. coli TOP 10, PCR verification by
primers 5AOX1/3AOX1 and sequencing, the correct
plasmid was then linearized with SalI and transformed
by electroporation into wild-type P. pastoris strain
GS115 and the positive transformant GS115-NpgA was
selected with histidine self-synthesis ability. The MSAS
encoding gene atX was first amplified from the plasmid
pESC-ATX recevied from Prof. Fujii [18]. The primers
AtxF/AtxR were used and a DNA fragment of 5437 bpwas harvested. It was then digested by EcoRI/NotI and li-
gated into EcoRI/NotI sites of the opened vector pPICZ
B to yield the expression plasmid pPICZ B-ATX. The
plasmid was transformed into E. coli Top 10, PCR verifi-
cation by primers BstPF/AtxR and tested by sequencing.
The correct plasmid was then amplified and digested by
PmeI and then transformed by electroporation into P.
pastoris GS115 and GS115-NpgA to form recombinant
strains GS115-ATX and GS115-NpgA-ATX.
Strain GS115-3.5 K, GS115-3.5 K-CT-SKL, GS115- NpgA-CT-SKL,
GS115-NpgA-CT and GS115-NpgA-SKL-CT-SKL
The commerial vector pPIC3.5 K acting as a control was
transformed P. pastoris GS115 to gain strain GS115-3.5 K.
A pksCT gene coding for citrinin synthase (PksCT) was
first identified by reverse transcription to harvest cDNA
[21]. Primer pairs CTAF/CTAR, CTBF/CTBR and CTCF/
CTCR were used to clone three fragments of pksCT and
then they were digested and ligated into pPICZ B succes-
sively to produce a plasmid pPICZ B-CT-SKL having the
complete pksCT gene with a SKL sequence for peroxi-
somal targeting. The plasmid was transformed into E. coli
Top 10, PCR verification by primers CTAF/CTCR and
tested by sequencing. The correct plasmid was then
amplified and digested by PmeI and then transformed by
electroporation into P. pastoris GS115-NpgA and GS115-
3.5 K to form GS115-NpgA-CT-SKL and GS115-3.5
K-CT-SKL, respectively. Then, primers Citrinin-F2/
Citrinin-R2 were used for cloning a pksCT fragment from
pPICZ B-CT-SKL and it was then digested by ClaI/NotI
and ligated into pPICZ B-CT-SKL opened with ClaI/NotI
to form pPICZ B-CT that removing the SKL sequence.
The pPICZ B-CT transformed GS115-NpgA to get strain
GS115-NpgA-CT. A pPIC3.5 K-NpgA-SKL plasmid was
then constructed similar to pPIC3.5 K-NpgA, which only
differed that involving a SKL sequence by primers
NpgAF/NpgASR1 followed by NpgAF/NpgASR2 to direct
NpgA into peroxisome. The pPIC3.5 K-NpgA-SKL
transformed GS115 to generate GS115-NpgA-SKL, which
was then transformed by pPICZ B-CT-SKL and produced
GS115-NpgA-SKL-CT-SKL.
Strain GS115-NpgA-HIS6
Genomic DNA of A. nidulans A1149 was first extracted.
Primers NpgA-HIS6-F/NpgA-HIS6-R were designed and
used for cloning npgA coding for PPTase from A.
nidulans A1149 by involving His-tag and a PCR product
of 1106 bp was obtained. The product was digested with
SacII/NotI and ligated into the same sites of the
digested vector pPICZ B to yield the expression vector
pPICZ B-NpgA-HIS6. After transforming into E. coli
TOP 10, PCR verification by primers 5AOX1/3AOX1
and sequencing, the correct plasmid was then linearized
with PmeI and transformed by electroporation into
Table 1 Primers used in this study





























a Restriction sites are underlined.
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produce the recombinant strain GS115-NpgA-HIS6
with zeocin resistence.
Strains E. coli BL21-ACP and E. coli BL21-ACPm
The UMA method was applied to identify the ACP
domain of the citrinin synthase (PksCT) from M.
purpureus [22]. Then primers AcpF/AcpR with NheI/
XhoI sites were designed based on the obtained DNA se-
quence. An ACP encoding DNA fragment of 534 bp was
then cloned using primers AcpF/AcpR and cDNA from
M. purpureus. The product was digested with NheI/XhoI
and ligated into NheI/XhoI sites of the digested vector
pET28a to yield the expression vector pET28a-ACP. The
plasmid was transformed into E. coli Top 10, PCR verifi-
cation by primers 5AOX1/3AOX1 and tested bysequencing. The correct plasmid was then transformed
into E. coli BL21 to yield recombinant strain BL21-ACP
for protein expression.
As PPtase carries coenzyme A to the hydroxyl of con-
served Ser residue in ACP to make it work, mutation at
serine would inactivate it. Thus DNA fragment of ACPm
were then constructed by over-lap PCR with primers
mutant5/mutant3 to change conserved serine at site 56
to alanine (Figure 5A). The strain BL21-ACPm was then
constructed following the same procedure of strain
pET28a-ACP.
Medium and agent
MGY medium: glycerol 10 g/L, YNB (Sigma) 6.7 g/L,
sterilized at 121°C for 20 min. Biotin was added to
0.4 mg/L after cooling.
Table 2 List of plasmids and strains in this work
Plasmids Characteristic(s) Reference
pET28a(+) KanR; T7 promoter based E. coli expression vector Novagen
pET28a-ACP pET28a(+) derivative carrying M. purpureus ACP encoded DNA This study
pET28a-ACPm pET28a(+) derivative carrying M. purpureus ACPm encoded DNA This study
pESC-ATX AmpR; URA3; PGAL1/GAL10-based yeast expression vector; commerial pESC-URA
derivative carrying atX gene
Moriguchi et al., 2006
pPIC3.5 K AmpR G418R; HIS4; PAOX1-based yeast expression vector Invitrogen
pPICZ B ZeocinR ; PAOX1-based expression yeast vector Invitrogen
pPIC3.5 K-NpgA pPIC3.5 K derivative carrying A. nidulans npgA gene This study
pPICZ B-NpgA-HIS6 pPICZ B derivative carrying A. nidulans npgA gene This study
pPICZ B-ATX pPICZ B derivative carrying A. terreus atX gene This study
pPICZ B-CT-SKL pPICZ B derivative carrying M. purpureus pksCT gene a P. pastoris SKL sequence This study
pPICZ B-CT pPICZ B derivative carrying M. purpureus pksCT gene This study
pPIC3.5 K-NpgA-SKL pPIC3.5 K derivative carrying A. nidulans npgA gene and a P. pastoris SKL sequence This study
Strains Characteristic(s) Reference
GS115 his4, AOX 1, AOX2 Invitrogen
GS115-NpgA-HIS6 Zeocin
R; GS115 with plasmid pPICZ B-NpgA-HIS6 This study
GS115-ATX ZeocinR; GS115 with plasmid pPICZ B-ATX This study
GS115-NpgA G418R; GS115 with plasmid pPIC3.5 K-NpgA This study
GS115-NpgA-ATX ZeocinR; G418R; GS115-NpgA with plasmid pPICZ B-ATX This study
GS115-3.5 K G418R; GS115 with pPIC3.5 K This study
GS115-3.5 K-CT-SKL ZeocinR; G418R; GS115-3.5 K with pPICZ B-CT-SKL This study
GS115-NpgA-CT ZeocinR; G418R; GS115-NpgA with plasmid pPICZ B-CT This study
GS115-NpgA-SKL G418R; GS115 with plasmid pPIC3.5 K-NpgA-SKL This study
GS115-NpgA-CT-SKL ZeocinR; G418R; GS115-NpgA with plasmid pPICZ B-CT-SKL This study
GS115-NpgA-SKL-CT-SKL ZeocinR; G418R; GS115-NpgA-SKL with plasmid pPICZ B-CT-SKL This study
E. coli TOP10 F’ [lacIq, Tn10(TetR)] mcrA φ80lacZΔM15 ΔlacX74 deoR recA1 Invitrogen
E. coli BL21 F– ompT hsdSB(rB
– mB
–) gal dcm (DE3) Invitrogen
BL21-ACP KanR; BL21 with plasmid pET28a-ACP This study
BL21-ACPm KanR; BL21 with plasmid pET28a-ACPm This study
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121°C for 20 min. Biotin was added to 0.4 mg/L and
methanol was added to 0.5% (v/v) after cooling.
BSM medium: 85% (w/v) H3PO4 13 mL/L, KOH
10.6 g/L, CaSO4 0.82 g/L, K2SO4 18.2 g/L, MgSO4 · 7H2O
14.9 g/L, glycerol 40 g/L, (NH4)2SO4 13.2 g/L, Antifoam
204 (Sigma) 0.33 mL/L, sterilized at 121°C for 30 min.
PTM1 solution was then added with 4.4 mL/L after
cooling.
PTM1 solution: CuSO4 · 5H2O 6.0 g/L, NaI 0.08 g/L,
MnSO4 · H2O 3.0 g/L, Na2MoO4 · 2H2O 0.2 g/L, HBO3
0.02 g/L, CoCl2 · 6H2O 0.914 g/L, ZnCl2 20.0 g/L,
FeSO4 · 7H2O 65.0 g/L, biotin 0.2 g/L, H2SO4 5.0 mL/L,
sterilized by filtration with 0.22 μm membrane filter and
stored at 4°C away from light.Glycerol feeding medium: glycerol 50% (w/v), sterilized
at 121°C for 30 min. PTM1 solution was then added
with 12 mL/L after cooling.
Methanol feeding medium: methanol (100%) with
12 mL/L PTM1.
SDS-PAGE electrophoresis buffer: 1 g SDS, 3.03 g Tris,
14.4 g Glycine, dissolved in 1 L ultrapure water.
Coomassie brilliant blue R250 solution: 1.0 g Coomassie
brilliant blue R250, 100 mL acetic acid, 300 mL ethanol,
dissolved in 1 L ultrapure water.
Electrophoretic destain solution: 32 mL acetic acid,
100 mL ethanol, ultrapure water added to 1 L.
SDS-PAGE loading buffer (5×): 1 g SDS, 2.5 mL 1 M
Tris–HCl (pH 6.8), 5 mL glycerol, 0.05 g Coomassie
brilliant blue, ultrapure water added to 10 mL.
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NaH2PO4, 10 mmol/L Na2HPO4, 0.5 mol/L NaCl,
20 mmol/L imidazole, pH 7.4.
Nickel-affinity chromatography elution buffer: 10 mmol/L
NaH2PO4, 10 mmol/L Na2HPO4, 0.5 mol/L NaCl,
500 mmol/L imidazole, pH 7.4.
Fluorescent labeling reaction buffer: 137 mM NaCl,
10 mM PBS (pH 7.4), 50 mM MgCl2.
CoA reaction buffer:75 mM Tris–HCl (pH 8.8),
10 mM MgCl2, 25 mM DTT.
20 mM Tris dialysis buffer: 20 mM Tris–HCl (pH 7.5),
150 mM NaCl.
Culture conditions
For GS115-NpgA-HIS6, a singal colony was inoculated
into a 250 mL shake flask containing 25 mL YPD
medium and cultivated at 30°C and 200 rpm for about
16 hours. Afterwards, the broth was transferred into
25 mL MGY medium to make the OD600 about 0.03.
The liquid was centrifugated at 3000 g for 5 min, washed
with MM medium twice and suspended with MM
medium to be OD600 = 1.0. Then 50 mL liquid was then
transferred into 500 mL baffled shake flask, covered two
layers of gauze and cultivated at 30°C and 200 rpm.
Methanol was fed every 24 hours to keep its concentra-
tion around 0.5% to induce protein expression.
For BL21-ACP and BL21-ACPm, a singal colony was
inoculated into a 250 mL shake flask containing 25 mL
LB medium with 50 μg/mL kanamycin and incubated at
37°C and 200 rpm for 12 hours. Then it was inoculated
into 25 mL LB medium with 50 μg/mL kanamycin in
250 mL shake flask by 1% (v/v) and cultivated at 37°C
and 200 rpm until OD600 = 0.6. Afterwards, 0.5 mM
IPTG was added to induce protein expression for
5 hours. The broth was centrifugated at 8000 g for 3 min,
washed with binding buffer and then stored at −20°C for
forward analysis.
The shake flask cultures of GS115-ATX, GS115-
NpgA-ATX, GS115- NpgA-CT-SKL, GS115-3.5 K-CT-
SKL, GS115-NpgA-CT and GS115-NpgA-SKL-CT-SKL
were as same as that of GS115-NpgA-HIS6. For 5-L
bioreactor, 300 mL seeds (OD600 = 6.0) cultivated with
MGY medium were collected and inoculated into a
5-L stirred-tank bioreactor (Shanghai Guoqiang Bio-
engineering Equipment Co., Ltd.) containing 3 L BSM
medium. The impeller equipped was double layer six-
blade Rushton disc turbine (RDT, 6.8 cm i.d.). The
lower impeller was 2.5 cm above the reactor bottom,
and the vertical distance between two impellers was
7.2 cm. Dissolved oxygen (DO) was measured using a
polarographic probe calibrated to 100% saturation for
aeration of 1 vvm at agitation of 600 rpm and tank inside
pressure of 0.02 Mpa. The broth pH was controlled at 5.0
by NH4OH. The temperature was kept at 30°C and theDO was controlled over 30% by adjusting agitation (not
higher than 800 rpm) and aeration (mixed gas of oxygen
and air if needed). When glycerol used up and DO repidly
increased, glycerol feeding medium was limitedly fed by
8 mL/L/h for 2 hours. The feeding rate may accelerate but
keep DO not lower than 30% until the wet cell weight
(WCW) reached 250 g/L. After glycerol was exhausted,
methanol feeding medium were fed by 4 mL/h/L for
2 hours and then slowly increased to 12 mL/h/L after 6
more hours and keep this rate until the end.
Protein expression and purification
To prepare PPtase, 30 OD600 units of GS115-NpgA-HIS6
cells were harvested by centrifugation at 6,000 g for
3 min, washed twice with ice-cold 50 mM binding
buffer (pH 7.4), and then frozen at −20°C. Cells were
thawed and resuspended in 1 mL binding buffer
(pH 7.4). It were mixed with 1.8 g glass beads (Biospec
Products, Bartlesville, OK) in a 2.0-mL screw-cap tube
followed by disruption with a bead disrupter (Mini-
BeadBeater-8; Biospec Products) for 8 cycles (1 min
vibrating and 1 min resting in ice for each cycle). The
lysate was centrifuged at 12,000 g for 30 min and the
solid was discarded. It was then filtrated by 0.22 μm
membrane and loading to the column that balanced well
with binding buffer by 0.5 mL/min. Afterwards, the
column was washed with binding buffer of 10 column
volumes to discard other proteins, followed by elution
buffer of 5 column volumes to collect the proteins. The
eluent was dialyzed by 20 mM Tris–HCl (pH 7.5) twice
and concentrated to 4 mg/mL by ultrafiltration, and
then used for in vitro experiment.
Cells of BL21-ACP and BL21-ACPm were centrifugated
and resuspended with 20 mM Tris–HCl (pH 7.5). The
proteins were then extracted by ultrasonic disruption
(300 w, 3 s on, 4 s off, 15 min) and collected by centri-
fugation at 12000 g and 4°C for 20–30 min (supernatant).
Eluted samples were analyzed on a Tris–Gly SDS-
PAGE gel (Invitrogen) and stained with Coomassie bril-
liant blue R250 solution.
Fluorescence labeling of CoA and bioactivity analysis
of PPTase
Preparation of Alexa Fluor 647-CoA: Dissolve 0.02 mg
Alexa Fluor 647-C2maleimide in 20 μL 50% DMSO. It
was then mixed with 1.0 mg CoA (0.53 μM) and 30%
DMSO (v/v), fed with fluorescent labeling reaction buf-
fer up to 245 μL, and reacted in dark for 1 hour. The
Alexa Fluor 647-CoA was then purified referring to pre-
vious study [25].
Preparation of Bodipy FL-CoA: Dissolve 1 mg bodipy
FL N-(2-aminoethyl)maleimide 40 μL DMSO. It was
then mixed with 0.8 mg CoA and 10% DMSO (v/v), fed
with fluorescent labeling reaction buffer up to 2 mL and
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extracted with ethyl acetate for three times and the
aqueous phase with Bodipy FL-CoA was collected.
The 25 μL reaction system consisted of 9.5 μM Alexa
Fluor 647-CoA (or 2 μL Bodipy-CoA), 0.16 μg/μL purified
His6-NpgA (PPtase), 5 μL (200 μg) protein supernant of
BL21-ACP(or BL21-ACPm) in CoA reaction buffer. After
incubated at room temperature for 10 min, loading buffer
was added to terminate the reaction and used for SDS-
PAGE after heated at 100°C for 2 min.
The KODAK In-Vivo multispectral imaging system
was used for the gel analysis by setting different wave
length of exciting light. After analysis, the gel was pho-
toed under white light after stained by Coomassie bril-
liant blue R250 solution and destained in electrophoretic
destain solution.
Extraction and identification of 6-MSA and citrinin
intermediate
For 6-MSA, 10 mL culture broth was centrifugated at
12000 g for 3 min. The supernatant was fully extracted with
20 mL ethyl acetate, and the organic phase was distilled
under reduced pressure and dissolved in 10 mL methanol.
It was used for HPLC analysis after filtration and dilution.
The cells was resuspended in 1 mL methanol and disrupted
by bead disrupter just as described before. The mixture was
then centrifugated at 12000 g for 3 min and the obtained
supernant was filtrated and diluted before HPLC analysis.
The sample was analyzed by a HPLC system of Agilent
1100 with a C18 column (Kromasil™, Sweden, 250 mm×
4.6 mm× 5 μm, 100 Å-spherical silica). It was eluted with a
gradiant strategy that 90% (v/v) A (water + 1% AcOH) and
10% (v/v) B (CH3CN+ 1% AcOH) to 20% (v/v) A and 80%
(v/v) B in 30 min, then to 100% (v/v) B in 2 min and kept
for 5 min. Afterwards, it was then gradiantly changed to
90% (v/v) A and 10% (v/v) B in 3 min. The elution condi-
tions were set as that flow rate of 1.0 mL/min, UV absorb-
ency of 306 nm and operating temperature of 30°C. The
compound was further confirmed by mass spectrometry
(EI-MS, Agilent G2577A), and also nuclear magnetic reson-
ance (NMR, BRUKER-400) with freeze-dried sample
dissolved in deuterated DMSO for 1HNMR analysis. For
quantifying the production of 6-MSA, the standard 6-MSA
(Shanghai Bepharm Co. Ltd) was used for standard curve
preparation by the same HPLC procedure. The extracted
6-MSA samples from fermentation broth were then diluted
properly for HPLC analysis and the 6-MSA production in
fermentation broth was then calculated. The compound
was also confirmed by EI-MS and 1HNMR analysis.
Extraction of citrinin intermediate was as same as
6-MSA. The HPLC system used was also the same. It
was eluted with a gradiant strategy that 90% (v/v) A
(water + 1% AcOH) and 10% (v/v) B (CH3CN + 1%
AcOH) to 30% (v/v) A and 70% (v/v) B in 25 min, thenimmediately change to 100% (v/v) B and kept for 5 min.
The elution conditions were set as that flow rate of
1.0 mL/min, UV absorbency of wide wavelength range
and operating temperature of 30°C.
Transcription and western blot analysis
Total RNAs were prepared by RiboPure™-Yeast Kit
(Ambion) following its standard protocol and were
subjected to DNase I treatment to exclude the genomic
DNA contaminant. Reverse transcription was performed
following ReverTra Ace transcription kit (Toyobo). For
western blot, samples were first prepared as same as that
described in the Section of Protein expression and puri-
fication. Total proteins were separated on polyacry-
lamide gels under denaturing conditions [31] and then
transferred onto a polyvinylidene difluoride (PVDF)
membrane using the electrophoretic transfer method
with rabbit anti-HA antibody (Tiangen) as the primary
antibody and peroxidase-conjugated goat anti-rabbit
immunoglobulin G (Jackson ImmunoResearch) as the
secondary antibody.
Additional file
Additional file 1: Figure S1. Time profiles of P. pastoris GS115 in 5-L
stirred-tank bioreactor fermentation with 6-MSA feeding. The first arrow
(24 h) indicated the starting point of glycerol feeding; The second arrow
(32 h) indicated the time point of 6-MSA feeding.
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